$CING
Cingulate Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$4.87
▼-0.41%-$0.020
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCingulate Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is CING down today? It is at $4.87 (-0.41%), and our scanner flagged it 12 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CING spikes, and full due diligence on CING — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CING 12 times in the last 30 days. Create a free account to track $CING, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
CING is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on CING today, peaking at 3.1x its normal volume.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Callahan Jennifer L. Officer | Acquired (grant/award) | +15K 0.1% of company | added 100% | 20K | n/a | Mar 9, 26 |
Callahan Jennifer L. Officer | Sold (automatic/other) | -6K 0.04% of company | sold 32% | 14K | n/a | Mar 9, 26 |
Brams Matthew Officer | Acquired (grant/award) | +5K 0.03% of company | added 97% | 9K | n/a | Mar 9, 26 |
Brams Matthew Officer | Sold (automatic/other) | -1K | sold 11% | 8K | n/a | Mar 9, 26 |
Schaffer Shane J. Officer | Acquired (grant/award) | +7K 0.05% of company | added 100% | 7K | n/a | Mar 9, 26 |
Schaffer Shane J. Officer | Sold (automatic/other) | -3K 0.02% of company | sold 42% | 4K | n/a | Mar 9, 26 |
Patel Nilay Dahyabhai Officer | Acquired (grant/award) | +5K 0.04% of company | n/a | 5K | n/a | Mar 9, 26 |
Patel Nilay Dahyabhai Officer | Sold (automatic/other) | -2K 0.01% of company | sold 38% | 3K | n/a | Mar 9, 26 |
Silva Raul R. Officer | Acquired (grant/award) | +5K 0.03% of company | added 100% | 6K | n/a | Mar 9, 26 |
Silva Raul R. Officer | Sold (automatic/other) | -2K 0.01% of company | sold 28% | 5K | n/a | Mar 9, 26 |
Hargroves Thomas Jeffrey Director | Bought (open market) | +97K 0.7% of company | added 100% | 97K | $490K at $5.04 | Feb 13, 26 |
Brams Matthew Officer | Bought (open market) | +2K 0.01% of company | added 72% | 5K | $10K at $5.04 | Feb 6, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
CING is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on CING today, peaking at 3.1x its normal volume.
CING last traded at $4.87, down 0.41% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Cingulate Inc. Common Stock (CING) is next expected to report earnings on Thursday, November 12, 2026, about 36 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CING Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CING 12 times in the last 30 days.
CING (Cingulate Inc. Common Stock) trades on XNAS, with a market cap of about $71M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CING for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CING discussion
Sign in to ask a question or join the discussion.